EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress

    NEXT STORY
    Global $8.2Bn Oligonucleotide Synthesis Market by 2024 – Opportunities in Emerging Asian Markets
    PREV STORY
    HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials

    MALVERN, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless ...

    author_avatar
    NASDAQ Market News

    Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million

    author_avatar
    NASDAQ Market News

    Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2

    author_avatar
    NASDAQ Market News